Apcegen
Biopharmaceutical company focused on developing affordable biologic therapeutics and regenerative medicine approaches. The organization emphasizes pathway engineering, antibody and biologics platform development, cell line and process development, analytical method development, and translation of discovery research into manufacturing-ready technologies for autoimmune disease, oncology (immuno-oncology), metabolic disease, and cardiovascular tissue engineering.
Industries
Nr. of Employees
small (1-50)
Products
Biosimilars
Pipeline work and platform capabilities to develop biosimilar therapeutic proteins.
Alternate/novel biologics
Development of alternate or novel biologic candidates targeting autoimmune and inflammatory pathways.
Regenerative medicine products
Research-stage regenerative-medicine approaches, including nanofiber-based cardiovascular tissue engineering.
Biosimilars
Pipeline work and platform capabilities to develop biosimilar therapeutic proteins.
Alternate/novel biologics
Development of alternate or novel biologic candidates targeting autoimmune and inflammatory pathways.
Regenerative medicine products
Research-stage regenerative-medicine approaches, including nanofiber-based cardiovascular tissue engineering.
Services
Cell line and expression vector development
Development of mammalian and microbial expression systems for recombinant proteins and antibodies.
Bioprocess development and scale-up
Early- and late-stage process development to optimize yield and product quality for biologics.
Antibody engineering and biologics R&D
Engineering and platform development for antibody-based therapeutics and biosimilars.
Analytical method development and validation
Development and validation of analytical assays and orthogonal characterization techniques for proteins and antibodies.
Regenerative medicine research (cardiovascular)
Development work on nanofiber-based cardiovascular tissue engineering approaches.
Cell line and expression vector development
Development of mammalian and microbial expression systems for recombinant proteins and antibodies.
Bioprocess development and scale-up
Early- and late-stage process development to optimize yield and product quality for biologics.
Antibody engineering and biologics R&D
Engineering and platform development for antibody-based therapeutics and biosimilars.
Analytical method development and validation
Development and validation of analytical assays and orthogonal characterization techniques for proteins and antibodies.
Regenerative medicine research (cardiovascular)
Development work on nanofiber-based cardiovascular tissue engineering approaches.
Expertise Areas
- Cell line development
- Bioprocessing and scale-up
- Antibody engineering and biologics development
- Analytical method development and protein characterization
Key Technologies
- Mammalian cell expression systems (CHO-based)
- Microbial periplasmic expression systems
- Antibody engineering platforms
- Bioprocess scale-up and production process development